GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that it will unveil the results of its U.S ...

The Cardiovascular Research Foundation ® (CRF ®) is pleased to announce the late-breaking clinical trials and science to be featured at TCT ® 2024. As the annual scientific symposium of CRF ® and the ...

NEW YORK – November 6, 2024 – The Cardiovascular Research Foundation ® (CRF ®) is pleased to announce that Symbiosis has won the TCT ® 2024 Shark Tank Innovation Competition for its development of an ...

As the pace of change accelerates in healthcare, the most pressing questions in cardiovascular medicine demand immediate answers. These challenges and more will be tackled head-on at the third annual ...

NEW YORK – April 11, 2025 – The TCT ® 2025 Career Achievement Award will be presented to Stephan Windecker, MD, during Transcatheter Cardiovascular Therapeutics ® (TCT ®), the annual scientific ...

The MarketWatch News Department was not involved in the creation of this content. Findings demonstrate safety, procedural success, and imaging-confirmed calcium modification using a next-generation ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

TCT 1232: Comparison of Distal Radial Artery Access in the Anatomical Snuffbox to Traditional Transradial Access for Coronary Angiography in the Veteran Population: A Retrospective Study Receive the ...

The first year of data from the TRISCEND II study of the Evoque tricuspid valve by Edwards Lifesciences Corp. confirm the notion that reduced regurgitation has a big impact on patient well-being.